Published on 13 Feb 2024 on GuruFocus.com via Yahoo Finance
IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares
On February 9, 2024, Yujiro Hata, the President and CEO of IDEAYA Biosciences Inc (NASDAQ:IDYA), sold 99,372 shares of the company. The transaction was reported in a SEC Filing. Following this transaction, the insider's total sales over the past year amount to 250,000 shares, with no reported purchases in the same period.
Warning! GuruFocus has detected 5 Warning Signs with IDYA.
IDEAYA Biosciences Inc is a precision medicine company focused on the discovery and development of targeted therapies for cancer. The company aims to improve the lives of cancer patients by developing personalized therapeutics that are designed to address the specific genetic and immunological drivers of an individual's cancer.